Bayer reaches $2 billion deal over future Roundup cancer claims

Bayer announced a formal agreement on a class plan designed to manage and resolve future Roundup™ cases. As part of the agreement, the company is committed to pay up to 2 billion U.S. Dollars to support future legal claims that its widely used weedkiller Roundup causes cancer, the German company said on Wednesday.

The company has said that decades of studies have shown Roundup and glyphosate are safe for human use.

Wednesday’s settlement would cover future claims brought by individuals who have been diagnosed with non-Hodgkin’s lymphoma and were exposed to Roundup before their diagnosis. The settlement also includes benefits for people who were exposed to Roundup and develop the cancer in the future.

Read the full article agreement here.

Read the full class plan agreement here.


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

© 2021

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber